Found 29 matching trials
Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis
PHASE4A total of 72 patients meeting the diagnostic criteria for acute cerebral v...
Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity
PHASE1Primary objective:
1. To assess the potential inhibitory and inducing effe...
Location
Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarmento de Beires
Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation
PHASE4Oral anticoagulation treatment (OAC) following clinically successful cathet...
Location
Heart Center Freiburg University Bad Krozingen
Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)
PHASE3The general aim of this study is to determine the comparative safety and ef...
Location
1160.46.01073 Boehringer Ingelheim Investigational Site
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
PHASE2The primary objective of this study is to establish the dose-response relat...
Location
1160.19.43004 Krankenhaus der Barmherzigen Schwestern Linz
Japanese Pradaxa PMS, Long Term
N/AThe study objective is to confirm appropriate use and safety profile of Pra...
Location
Nippon Boehringer Ingelheim Co., Ltd
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
PHASE4More than 25% of patients referred for diagnostic coronary angiography and ...
Location
Cardiac lntensive Care Unit, First Department of Cardiology, University Clinical Centre in Gdańsk
Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran
N/AThe primary objective in this cross-sectional study is to assess the preval...
Location
Hamilton Health Sciences Corporation
Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048
PHASE2To determine the long term safety and efficacy of BIBR 1048 in patients wit...
Location
1160.42.10003 Boehringer Ingelheim Investigational Site
Cognitive Impairment Related to Atrial Fibrillation Prevention Trial
PHASE4Cognitive and functional decline observed in atrial fibrillation (AF) patie...
Location
Federal Univeristy of Minas Gerais